U.S. market Closed. Opens in 17 hours 29 minutes

ACRX | AcelRx Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue651.00K1.77M2.82M5.42M2.29M2.15M8.00M17.36M19.26M5.22M29.50M2.39M1.07MN/AN/AN/A
Cost of RevenueN/A2.59M3.75M6.03M6.81M3.98M10.66M12.31M1.77MN/AN/AN/AN/AN/AN/AN/A
Gross Profit651.00K-820.00K-935.00K-616.00K-4.52M-1.82M-2.66M5.04M17.49MN/A29.50MN/A1.07MN/AN/AN/A
Operating Expenses17.54M30.86M35.03M40.35M49.69M33.90M36.02M37.00M36.69M42.87M36.17M32.11M20.42MN/AN/AN/A
Selling, General & Admin11.99M25.67M30.93M36.33M45.03M20.77M16.61M15.60M14.20M18.35M9.88M7.20M6.80M3.99M3.53M2.37M
Research & Development5.55M5.19M4.09M4.02M4.66M13.14M19.41M21.40M22.49M24.52M26.29M24.91M13.62M8.19M15.50M18.32M
Other Operating ExpensesN/A84.05MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-12.19M-19.03M-20.69M
Operating Income-16.89M-36.63M-35.97M-40.96M-54.20M-35.73M-38.68M-31.96M-19.20M-37.65M-6.67M-29.71M-19.35M-12.19M-19.03M-20.69M
Other Expenses / Income6.60M84.40M871.00K588.00K968.00K-11.42M-13.53M-11.23M-4.44M4.30M-16.76M-3.65M1.51M-765.00K-1.09M28.00K
Before Tax Income-10.29M47.77M-35.09M-40.38M-53.24M-47.15M-52.21M-43.19M-23.64M-33.35M-23.43M-33.36MN/AN/A-20.12M-20.66M
Income Tax ExpensesN/A13.00K5.00K4.00K3.00K2.00K-701.00K-34.00K760.00KN/AN/AN/AN/AN/AN/AN/A
Net Income-10.29M47.76M-35.10M-40.38M-53.24M-47.15M-51.51M-43.16M-24.40M-33.35M-23.43M-33.36M-20.10M-14.34M-20.12M-20.66M
Interest Expenses-134.00K1.15M2.29M3.31M1.20M12.56M14.04M12.15M5.41M2.64M16.76M2.28M2.31M1.40M1.24M404.00K
Basic Shares Outstanding14.26B7.39M5.99M4.26M3.96M2.92M2.34M45.31M44.30M43.43M39.75M22.12M17.34M656.65K5.75M656.65K
Diluted Shares Outstanding14.26B7.41M5.99M4.26M3.96M2.92M2.34M45.31M44.47M44.32M39.75M22.12M17.34M656.65K5.75M656.65K
EBITDA-16.89M-30.18M-30.83M-37.07M-52.04M-34.59M-36.43M-28.99M-16.25M-29.85M-6.07M-30.48M-17.28M-10.94M-18.52M-19.82M
EBITDA Margin-2,594.32%-1,704.29%-1,094.04%-684.45%-2,273.44%-1,608.04%-455.63%-167.00%-84.36%-572.13%-20.59%-1,272.97%-1,611.85%0.00%0.00%0.00%
EBIT-10.42M48.92M-32.80M-37.07M-52.04M-34.59M-38.17M-31.04M-18.23M-30.71M-6.67M-31.08M-17.79M-12.95M-18.88M-20.26M
EBIT Margin-1,600.77%2,762.34%-1,164.05%-684.45%-2,273.44%-1,608.04%-477.45%-178.83%-94.66%-588.73%-22.60%-1,298.25%-1,659.70%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙